The Institute for Functional Medicine (IFM) has named Amy R. Mack as IFM’s next chief executive officer (CEO), effective April 1, 2018. She succeeds Laurie Hofmann, MPH, who has been serving IFM in various Board and executive leadership roles since 2001.
“I have had the pleasure of working side by side with Amy Mack in her current role as COO over the last six months,” said Hofmann. “She brings a strong non-profit management track record and a disciplined approach to organizational and staff development, strategic planning and execution, operations, collaborations and partnerships, fiscal oversight, and more. In addition, her values and commitment to achieving our mission are strongly aligned with IFM’s focus on leadership, innovation and inspiration—all of which serve the widespread adoption of functional medicine. I am confident in her abilities to serve as chief executive officer and to lead IFM in this very important and exciting next stage of maturation, challenges and opportunities.”
Hofmann will continue in a leadership and mentorship role as IFM integrates Mack as CEO and begins the search for the president of medical education and research. She will also serve as Board Chair to lead the Board of Directors in a strategic development and board expansion process.
“IFM provides practitioners with the most comprehensive functional medicine education and training available worldwide. Evidence-based and clinically proven, functional medicine is driving critical systems changes,” said Mack. “I am excited to serve as CEO to advance the role IFM continues to play in the changing landscape and future of health care. I want to thank Laurie Hofmann for her years of commitment and leadership to IFM, and I look forward to working with her in her role as Board Chair as we build upon the strong foundation she and the Board of Directors have established.”
For more information, visit www.ifm.org.